In the Matter of Certain Vaginal Ring Birth Control Devices; Notice of Investigation, 17444-17446 [2011-7295]
Download as PDF
<![CDATA[
17444
Federal Register / Vol. 76, No. 60 / Tuesday, March 29, 2011 / Notices
management topics of interest to the
Council raised during the planning
process.
These meetings are anticipated to
occur monthly, and may occur as
frequently as every two weeks during
intensive phases of the planning
process. Dates, times and agendas for
additional meetings may be determined
at future Advisory Council Meetings,
and will be published in the Federal
Register, announced through local
media and on the BLM’s Web site for
the Dominguez-Escalante planning
effort, https://www.blm.gov/co/st/en/nca/
denca/denca_rmp.html.
These meetings are open to the
public. The public may present written
comments to the Council. Each formal
Council meeting will have time
allocated at the beginning and end of
each meeting for hearing public
comments. Depending on the number of
persons wishing to comment and time
available, the time for individual, oral
comments may be limited at the
discretion of the chair.
Helen M. Hankins,
State Director.
[FR Doc. 2011–7297 Filed 3–28–11; 8:45 am]
BILLING CODE 4310–JB–P
DEPARTMENT OF THE INTERIOR
National Park Service
[2253–665]
Notice of Inventory Completion:
Colorado Historical Society (History
Colorado), Denver, CO
National Park Service, Interior.
Notice.
AGENCY:
jlentini on DSKJ8SOYB1PROD with NOTICES
ACTION:
Notice is here given in accordance
with the Native American Graves
Protection and Repatriation Act
(NAGPRA), 25 U.S.C. 3003, of the
completion of an inventory of human
remains in the possession and control of
the Colorado Historical Society (History
Colorado), Denver, CO. The human
remains were removed from Howiri
Ruin (LA 71), Taos County, NM.
This notice is published as part of the
National Park Service’s administrative
responsibilities under NAGPRA, 25
U.S.C. 3003(d)(3). The determinations in
this notice are the sole responsibility of
the museum, institution, or Federal
agency that has control of the Native
American human remains. The National
Park Service is not responsible for the
determinations in this notice.
A detailed assessment of the human
remains was made by the Colorado
Historical Society (History Colorado)
VerDate Mar<15>2010
16:37 Mar 28, 2011
Jkt 223001
professional staff in consultation with
representatives of the Hopi Tribe of
Arizona; Navajo Nation, Arizona, New
Mexico & Utah; Ohkay Owingeh, New
Mexico; Pueblo of Acoma, New Mexico;
Pueblo of Cochiti, New Mexico; Pueblo
of Isleta, New Mexico; Pueblo of Jemez,
New Mexico; Pueblo of Laguna, New
Mexico; Pueblo of Nambe, New Mexico;
Pueblo of Picuris, New Mexico; Pueblo
of Pojoaque, New Mexico; Pueblo of San
Ildefonso, New Mexico; Pueblo of Santa
Ana, New Mexico; Pueblo of Santa
Clara, New Mexico; Pueblo of Taos,
New Mexico; Pueblo of Tesuque, New
Mexico; Pueblo of Zia, New Mexico;
Ysleta Del Sur Pueblo of Texas; and
Zuni Tribe of the Zuni Reservation, New
Mexico. The Kew Pueblo, New Mexico
(formerly the Pueblo of Santo Domingo);
Pueblo of Sandia, New Mexico; and
Pueblo of San Felipe, New Mexico, were
contacted for consultation purposes, but
did not attend the consultation
meetings.
In 1958, human remains representing
a minimum of one individual were
removed from Howiri Ruin (LA 71), in
Taos County, NM, by J.H. Gerault and
Eugene Stigall. The remains were
donated to the Huerfano County
Museum in Colorado. In November
1989, the individual was transferred to
the Colorado Historical Society. No
known individual was identified. No
associated funerary objects are present.
Howiri Ruin is a large 15th century
multi-storied Pueblo village near Ojo
Caliente, NM. In 1958, Howiri Ruin had
multiple owners, including private
citizens and the State of New Mexico. It
is not known if the individual was
removed from private or public land
within Howiri Ruin. Colorado Historical
Society has accepted NAGPRA
responsibilities for this individual.
Osteological analysis by Colorado State
University confirmed that the remains
are of a Native American infant. Oral
tradition and archeological evidence
indicate the site was occupied by
ancestors of present-day Northern Tewaspeaking Pueblos.
Officials of the Colorado Historical
Society have determined, pursuant to 25
U.S.C. 3001(9), that the human remains
described above represent the physical
remains of one individual of Native
American ancestry. Officials of the
Colorado Historical Society also have
determined, pursuant to 25 U.S.C.
3001(2), that there is a relationship of
shared group identity that can be
reasonably traced between the Native
American human remains and the
Ohkay Owingeh, New Mexico; Pueblo of
Nambe, New Mexico; Pueblo of
Pojoaque, New Mexico; Pueblo of San
Ildefonso, New Mexico; Pueblo of Santa
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
Clara, New Mexico; and Pueblo of
Tesuque, New Mexico.
Representatives of any other Indian
Tribe that believes itself to be culturally
affiliated with the human remains
should contact Bridget Ambler, Curator
of Material Culture, Colorado Historical
Society (History Colorado), 1560
Broadway, Suite 400, Denver, CO 80202,
telephone (303) 866–2303, before April
28, 2011. Repatriation of the human
remains to the Ohkay Owingeh, New
Mexico; Pueblo of Nambe, New Mexico;
Pueblo of Pojoaque, New Mexico;
Pueblo of San Ildefonso, New Mexico;
Pueblo of Santa Clara, New Mexico; and
Pueblo of Tesuque, New Mexico, may
proceed after that date if no additional
claimants come forward.
The Colorado Historical Society
(History Colorado) is responsible for
notifying the Hopi Tribe of Arizona;
Kewa Pueblo, New Mexico; Navajo
Nation, Arizona, New Mexico & Utah;
Ohkay Owingeh, New Mexico; Pueblo of
Acoma, New Mexico; Pueblo of Cochiti,
New Mexico; Pueblo of Isleta, New
Mexico; Pueblo of Jemez, New Mexico;
Pueblo of Laguna, New Mexico; Pueblo
of Nambe, New Mexico; Pueblo of
Picuris, New Mexico; Pueblo of
Pojoaque, New Mexico; Pueblo of San
Felipe, New Mexico; Pueblo of San
Ildefonso, New Mexico; Pueblo of
Sandia, New Mexico; Pueblo of Santa
Ana, New Mexico; Pueblo of Santa
Clara, New Mexico; Pueblo of Taos,
New Mexico; Pueblo of Tesuque, New
Mexico; Pueblo of Zia, New Mexico,
Ysleta Del Sur Pueblo of Texas; and
Zuni Tribe of the Zuni Reservation, New
Mexico, that this notice has been
published.
Dated: March 23, 2011.
Sherry Hutt,
Manager, National NAGPRA Program.
[FR Doc. 2011–7319 Filed 3–28–11; 8:45 am]
BILLING CODE 4312–50–P
INTERNATIONAL TRADE
COMMISSION
[Inv. No. 337–TA–768]
In the Matter of Certain Vaginal Ring
Birth Control Devices; Notice of
Investigation
U.S. International Trade
Commission.
ACTION: Institution of investigation
pursuant to 19 U.S.C. 1337.
AGENCY:
Notice is hereby given that a
complaint was filed with the U.S.
International Trade Commission on
February 25, 2011, under section 337 of
the Tariff Act of 1930, as amended, 19
SUMMARY:
E:\FR\FM\29MRN1.SGM
29MRN1
jlentini on DSKJ8SOYB1PROD with NOTICES
Federal Register / Vol. 76, No. 60 / Tuesday, March 29, 2011 / Notices
U.S.C. 1337, on behalf of Femina
Pharma Incorporated of Miami, Florida.
Letters supplementing the complaint
were filed on March 11 and 15, 2011.
The complaint alleges violations of
section 337 based upon the importation
into the United States, the sale for
importation, and the sale within the
United States after importation of
certain vaginal ring birth control devices
by reason of infringement of claim 1 of
U.S. Patent No. 6,086,909 (‘‘the ‘909
patent’’). The complaint further alleges
that an industry in the United States
exists as required by subsection (a)(2) of
section 337.
The complainant requests that the
Commission institute an investigation
and, after the investigation, issue an
exclusion order and cease and desist
orders.
ADDRESSES: The complaint, except for
any confidential information contained
therein, is available for inspection
during official business hours (8:45 a.m.
to 5:15 p.m.) in the Office of the
Secretary, U.S. International Trade
Commission, 500 E Street, SW., Room
112, Washington, DC 20436, telephone
202–205–2000. Hearing impaired
individuals are advised that information
on this matter can be obtained by
contacting the Commission’s TDD
terminal on 202–205–1810. Persons
with mobility impairments who will
need special assistance in gaining access
to the Commission should contact the
Office of the Secretary at 202–205–2000.
General information concerning the
Commission may also be obtained by
accessing its internet server at https://
www.usitc.gov. The public record for
this investigation may be viewed on the
Commission’s electronic docket (EDIS)
at https://edis.usitc.gov.
FOR FURTHER INFORMATION CONTACT:
Office of Unfair Import Investigations,
U.S. International Trade Commission,
telephone (202) 205–2560.
Authority: The authority for
institution of this investigation is
contained in section 337 of the Tariff
Act of 1930, as amended, and in section
210.10 of the Commission’s Rules of
Practice and Procedure, 19 CFR 210.10
(2010).
Scope Of Investigation: Having
considered the complaint, the U.S.
International Trade Commission, on
March 23, 2011, ordered that—
(1) Pursuant to subsection (b) of
section 337 of the Tariff Act of 1930, as
amended, an investigation be instituted
to determine whether there is a
violation of subsection (a)(1)(B) of
section 337 in the importation into the
United States, the sale for importation,
or the sale within the United States after
VerDate Mar<15>2010
16:37 Mar 28, 2011
Jkt 223001
importation of certain vaginal ring birth
control devices that infringe claim 1 of
the ‘909 patent, and whether an
industry in the United States exists as
required by subsection (a)(2) of section
337;
(2) Pursuant to Commission Rule
210.50(b)(1), 19 CFR 210.50(b)(1), the
presiding administrative law judge shall
take evidence or other information and
hear arguments from the parties and
other interested persons with respect to
the public interest in this investigation,
as appropriate, and provide the
Commission with findings of fact and a
recommended determination on this
issue;
(3) For the purpose of the
investigation so instituted, the following
are hereby named as parties upon which
this notice of investigation shall be
served:
(a) The complainant is: Femina
Pharma Incorporated, 3470 E. Coast
Ave., Suite H502, Miami, FL 33137.
(b) The respondents are the following
entities alleged to be in violation of
section 337, and are the parties upon
which the complaint is to be served:
Merck & Co., Inc., One Merck Drive,
Whitehouse Station, NJ 08889;
Schering Plough Corporation, 2000
Galloping Hill Road, Kenilworth, NJ
07033;
Organon USA, Inc., 100 Rodolphe
Street, Durham, North Carolina 27712;
N.V. Organon, Molenstraat 110, Oss,
Netherlands, 5340 BH;
CVS Caremark Corporation, One CVS
Drive, Woonsocket, RI 02895;
CVS Pharmacy, Inc., One CVS Drive,
Woonsocket, RI 02895;
Wal-Mart Stores, Inc., 702 S.W. 8th St.,
Bentonville, AR 72716;
Walgreens Co., 200 Wilmont RD,
Deerfield, IL 60015;
The Canamerican Drugs Inc., d/b/a,
https://www.77Canadapharmacy.com.
https://www.medcentercanada.com.
https://www.tigerdrugs.com . 77
Canada Pharmacy, 8–1421 St. James
Street, Winnipeg, MB, R3H 0Y9,
Canada.
The Canamerican Global Inc., d/b/a,
https://www.canamericanglobal.com,
77 Canada Pharmacy, 8–1421 St.
James Street, Winnipeg, MB, R3H
0Y9, Canada;
Canadian Med Service, d/b/a, https://
www.canadianmedservices.com, 77
Canada Pharmacy, 8–1421 St. James
Street, Winnipeg, MB, R3H 0Y9,
Canada;
Panther Meds Inc., d/b/a, https://
www.panthermeds.com, 77 Canada
Pharmacy, 8–1421 St. James Street,
Winnipeg, MB, R3H 0Y9, Canada;
Canada Drugs Online, d/b/a, https://
www.Canadadrugsonline.com, Unit
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
17445
#202A, 8322–130th Street, Surrey,
British Columbia, Canada V3W 8J;
Drug World Canada, d/b/a, https://
www.drugworldcanada.com, Unit
#202A, 8322–130th Street, Surrey,
British Columbia, Canada V3W 8J9;
CanDrug Health Solutions Inc., d/b/a,
https://www.candrug.com, Unit
#202A,, 8322–130th Street, Surrey,
British Columbia, Canada V3W 8J9;
Big Mountain Drugs, d/b/a, https://
www.bigmountaindrugs.com, Unit
#202A, 8322–130th Street, Surrey,
British Columbia, Canada V3W 8J9;
BestBuyRx.com, d/b/a, https://
www.bestbuyrx.com, Unit #202A,
8322–130th Street, Surrey, British
Columbia, Canada V3W 8J9;
Blue Sky Drugs, d/b/a, https://
www.Blueskydrugs.com, Unit #202A,
8322–130th Street, Surrey, British
Columbia, Canada V3W 8J9;
ABC Online Pharmacy, d/b/a, https://
www.abconlinepharmacy.com, 200–
7382 Winston Street, Burnaby, British
Columbia, V5A 2G9 Canada;
Canadadrugs.com LP, d/b/a, https://
www.Canadadrugs.com, 24 Terracon
Place, Winnipeg, Manitoba, Canada
R2J 4G7.
North Drug Store, d/b/a, https://
www.northdrugstore.com, 266
Graham Avenue, P.O. Box 1074
Station Main, Winnipeg, Manitoba,
R3C 2X4 Canada;
Canada Pharmacy, d/b/a, https://
www.CanadaPharmacy.com, 477
Peace Portal Dr Suite #180, Blaine,
WA 98230;
(c) The Commission investigative
attorney, party to this investigation, is
the Office of Unfair Import
Investigations, U.S. International Trade
Commission, 500 E Street, SW., Suite
401, Washington, DC 20436; and
(4) For the investigation so instituted,
the Honorable Paul J. Luckern, Chief
Administrative Law Judge, U.S.
International Trade Commission, shall
designate the presiding Administrative
Law Judge.
Responses to the complaint and the
notice of investigation must be
submitted by the named respondents in
accordance with section 210.13 of the
Commission’s Rules of Practice and
Procedure, 19 CFR 210.13. Pursuant to
19 CFR 201.16(d)–(e) and 210.13(a),
such responses will be considered by
the Commission if received not later
than 20 days after the date of service by
the Commission of the complaint and
the notice of investigation. Extensions of
time for submitting responses to the
complaint and the notice of
investigation will not be granted unless
good cause therefor is shown.
Failure of a respondent to file a timely
response to each allegation in the
E:\FR\FM\29MRN1.SGM
29MRN1
17446
Federal Register / Vol. 76, No. 60 / Tuesday, March 29, 2011 / Notices
complaint and in this notice may be
deemed to constitute a waiver of the
right to appear and contest the
allegations of the complaint and this
notice, and to authorize the
administrative law judge and the
Commission, without further notice to
the respondent, to find the facts to be as
alleged in the complaint and this notice
and to enter an initial determination
and a final determination containing
such findings, and may result in the
issuance of an exclusion order or a cease
and desist order or both directed against
the respondent.
By order of the Commission.
Issued: March 23, 2011.
James R. Holbein,
Acting Secretary to the Commission.
[FR Doc. 2011–7295 Filed 3–28–11; 8:45 am]
BILLING CODE P
DEPARTMENT OF LABOR
Office of the Secretary
Agency Information Collection
Activities; Submission for OMB
Review; Comment Request; Notice of
Alleged Safety or Health Hazards
ACTION:
Notice.
The Department of Labor
(DOL) hereby announces the submission
of the Occupational Safety and Health
Administration (OSHA) sponsored
information collection request (ICR)
titled, ‘‘Notice of Alleged Safety or
Health Hazards,’’ to the Office of
Management and Budget (OMB) for
review and approval for continued use
in accordance with the Paperwork
Reduction Act of 1995 (Pub. L. 104–13,
44 U.S.C. chapter 35).
DATES: Submit comments on or before
April 28, 2011.
ADDRESSES: A copy of this ICR, with
applicable supporting documentation;
including a description of the likely
respondents, proposed frequency of
response, and estimated total burden
may be obtained from the RegInfo.gov
Web site, https://www.reginfo.gov/
public/do/PRAMain, on the day
following publication of this notice or
by contacting Michel Smyth by
telephone at 202–693–4129 (this is not
a toll-free number) or sending an e-mail
to DOL_PRA_PUBLIC@dol.gov.
Submit comments about this request
to the Office of Information and
Regulatory Affairs, Attn: OMB Desk
Officer for the Department of Labor,
Occupational Safety and Health
Administration (OSHA), Office of
Management and Budget, Room 10235,
jlentini on DSKJ8SOYB1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
16:37 Mar 28, 2011
Jkt 223001
Washington, DC 20503, Telephone:
202–395–4816/Fax: 202–395–6881
(these are not toll-free numbers), e-mail:
OIRA_submission@omb.eop.gov.
FOR FURTHER INFORMATION CONTACT:
Contact Michel Smyth by telephone at
202–693–4129 (this is not a toll-free
number) or by e-mail at
DOL_PRA_PUBLIC@dol.gov.
SUPPLEMENTARY INFORMATION:
Respondents use the Notice of Alleged
Safety or Health Hazards, Form OSHA–
7, to report unhealthful and/or unsafe
conditions in the workplace to the
OSHA. OSHAct section 8(f)(1)
authorizes employee reports. The OSHA
uses this information to evaluate the
alleged hazards and to schedule an
inspection.
This information collection is subject
to the PRA. A Federal agency generally
cannot conduct or sponsor a collection
of information, and the public is
generally not required to respond to an
information collection, unless it is
currently approved by the OMB under
the PRA and displays a currently valid
OMB Control Number. In addition,
notwithstanding any other provisions of
law, no person shall generally be subject
to penalty for failing to comply with a
collection of information if the
collection of information does not
display a currently valid OMB control
number. See 5 CFR 1320.5(a) and
1320.6. The DOL obtains OMB approval
for this information collection under
OMB Control Number 1218–0064. The
current OMB approval is scheduled to
expire on March 31, 2011; however, it
should be noted that information
collections submitted to the OMB
receive a month-to-month extension
while they undergo review. For
additional information, see the related
notice published in the Federal Register
on January 13, 2011 (76 FR 2417).
Interested parties are encouraged to
send comments to the OMB, Office of
Information and Regulatory Affairs at
the address shown in the ADDRESSES
section within 30 days of publication of
this notice in the Federal Register. In
order to help ensure appropriate
consideration, comments should
reference OMB Control Number 1218–
0064. The OMB is particularly
interested in comments that:
• Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
• Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
including the validity of the
methodology and assumptions used;
• Enhance the quality, utility, and
clarity of the information to be
collected; and
• Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses.
Agency: Occupational Safety and
Health Administration (OSHA).
Title of Collection: Notice of Alleged
Safety or Health Hazards, Form OSHA–
7.
OMB Control Number: 1218–0064.
Affected Public: Individuals and
Households.
Total Estimated Number of
Respondents: 50,715.
Total Estimated Number of
Responses: 50,715.
Total Estimated Annual Burden
Hours: 13,414.
Total Estimated Annual Costs Burden:
$1,116.
Dated: March 24, 2011.
Michel Smyth,
Departmental Clearance Officer.
[FR Doc. 2011–7362 Filed 3–28–11; 8:45 am]
BILLING CODE 4510–26–P
DEPARTMENT OF LABOR
Employment and Training
Administration
[TA–W–75,090]
Wausau Daily Herald Advertising
Production Division, a Subsidiary of
Gannett Co., Inc.; Wausau, WI; Notice
of Affirmative Determination Regarding
Application for Reconsideration
By application dated March 1, 2011
(received March 7, 2011), the petitioner
requested administrative
reconsideration of the negative
determination regarding workers’
eligibility to apply for Trade Adjustment
Assistance (TAA) applicable to workers
and former workers of Wausau Daily
Herald, Advertising Production
Division, a subsidiary of Gannett Co.,
Inc., Wausau, Wisconsin (subject firm).
The determination was issued on
February 11, 2011. The Department’s
Notice of Determination will soon be
published in the Federal Register. The
workers produce newspaper
advertisements.
The negative determination was based
on the findings that, during the period
E:\FR\FM\29MRN1.SGM
29MRN1
]]>Agencies
[Federal Register Volume 76, Number 60 (Tuesday, March 29, 2011)]
[Notices]
[Pages 17444-17446]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-7295]
=======================================================================
-----------------------------------------------------------------------
INTERNATIONAL TRADE COMMISSION
[Inv. No. 337-TA-768]
In the Matter of Certain Vaginal Ring Birth Control Devices;
Notice of Investigation
AGENCY: U.S. International Trade Commission.
ACTION: Institution of investigation pursuant to 19 U.S.C. 1337.
-----------------------------------------------------------------------
SUMMARY: Notice is hereby given that a complaint was filed with the
U.S. International Trade Commission on February 25, 2011, under section
337 of the Tariff Act of 1930, as amended, 19
[[Page 17445]]
U.S.C. 1337, on behalf of Femina Pharma Incorporated of Miami, Florida.
Letters supplementing the complaint were filed on March 11 and 15,
2011. The complaint alleges violations of section 337 based upon the
importation into the United States, the sale for importation, and the
sale within the United States after importation of certain vaginal ring
birth control devices by reason of infringement of claim 1 of U.S.
Patent No. 6,086,909 (``the `909 patent''). The complaint further
alleges that an industry in the United States exists as required by
subsection (a)(2) of section 337.
The complainant requests that the Commission institute an
investigation and, after the investigation, issue an exclusion order
and cease and desist orders.
ADDRESSES: The complaint, except for any confidential information
contained therein, is available for inspection during official business
hours (8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S.
International Trade Commission, 500 E Street, SW., Room 112,
Washington, DC 20436, telephone 202-205-2000. Hearing impaired
individuals are advised that information on this matter can be obtained
by contacting the Commission's TDD terminal on 202-205-1810. Persons
with mobility impairments who will need special assistance in gaining
access to the Commission should contact the Office of the Secretary at
202-205-2000. General information concerning the Commission may also be
obtained by accessing its internet server at https://www.usitc.gov. The
public record for this investigation may be viewed on the Commission's
electronic docket (EDIS) at https://edis.usitc.gov.
FOR FURTHER INFORMATION CONTACT: Office of Unfair Import
Investigations, U.S. International Trade Commission, telephone (202)
205-2560.
Authority: The authority for institution of this investigation is
contained in section 337 of the Tariff Act of 1930, as amended, and in
section 210.10 of the Commission's Rules of Practice and Procedure, 19
CFR 210.10 (2010).
Scope Of Investigation: Having considered the complaint, the U.S.
International Trade Commission, on March 23, 2011, ordered that--
(1) Pursuant to subsection (b) of section 337 of the Tariff Act of
1930, as amended, an investigation be instituted to determine whether
there is a violation of subsection (a)(1)(B) of section 337 in the
importation into the United States, the sale for importation, or the
sale within the United States after importation of certain vaginal ring
birth control devices that infringe claim 1 of the `909 patent, and
whether an industry in the United States exists as required by
subsection (a)(2) of section 337;
(2) Pursuant to Commission Rule 210.50(b)(1), 19 CFR 210.50(b)(1),
the presiding administrative law judge shall take evidence or other
information and hear arguments from the parties and other interested
persons with respect to the public interest in this investigation, as
appropriate, and provide the Commission with findings of fact and a
recommended determination on this issue;
(3) For the purpose of the investigation so instituted, the
following are hereby named as parties upon which this notice of
investigation shall be served:
(a) The complainant is: Femina Pharma Incorporated, 3470 E. Coast
Ave., Suite H502, Miami, FL 33137.
(b) The respondents are the following entities alleged to be in
violation of section 337, and are the parties upon which the complaint
is to be served:
Merck & Co., Inc., One Merck Drive, Whitehouse Station, NJ 08889;
Schering Plough Corporation, 2000 Galloping Hill Road, Kenilworth, NJ
07033;
Organon USA, Inc., 100 Rodolphe Street, Durham, North Carolina 27712;
N.V. Organon, Molenstraat 110, Oss, Netherlands, 5340 BH;
CVS Caremark Corporation, One CVS Drive, Woonsocket, RI 02895;
CVS Pharmacy, Inc., One CVS Drive, Woonsocket, RI 02895;
Wal-Mart Stores, Inc., 702 S.W. 8th St., Bentonville, AR 72716;
Walgreens Co., 200 Wilmont RD, Deerfield, IL 60015;
The Canamerican Drugs Inc., d/b/a, https://www.77Canadapharmacy.com.
https://www.medcentercanada.com. https://www.tigerdrugs.com . 77 Canada
Pharmacy, 8-1421 St. James Street, Winnipeg, MB, R3H 0Y9, Canada.
The Canamerican Global Inc., d/b/a, https://www.canamericanglobal.com,
77 Canada Pharmacy, 8-1421 St. James Street, Winnipeg, MB, R3H 0Y9,
Canada;
Canadian Med Service, d/b/a, https://www.canadianmedservices.com, 77
Canada Pharmacy, 8-1421 St. James Street, Winnipeg, MB, R3H 0Y9,
Canada;
Panther Meds Inc., d/b/a, https://www.panthermeds.com, 77 Canada
Pharmacy, 8-1421 St. James Street, Winnipeg, MB, R3H 0Y9, Canada;
Canada Drugs Online, d/b/a, https://www.Canadadrugsonline.com, Unit
202A, 8322-130th Street, Surrey, British Columbia, Canada V3W
8J;
Drug World Canada, d/b/a, https://www.drugworldcanada.com, Unit
202A, 8322-130th Street, Surrey, British Columbia, Canada V3W
8J9;
CanDrug Health Solutions Inc., d/b/a, https://www.candrug.com, Unit
202A,, 8322-130th Street, Surrey, British Columbia, Canada V3W
8J9;
Big Mountain Drugs, d/b/a, https://www.bigmountaindrugs.com, Unit
202A, 8322-130th Street, Surrey, British Columbia, Canada V3W
8J9;
BestBuyRx.com, d/b/a, https://www.bestbuyrx.com, Unit 202A,
8322-130th Street, Surrey, British Columbia, Canada V3W 8J9;
Blue Sky Drugs, d/b/a, https://www.Blueskydrugs.com, Unit 202A,
8322-130th Street, Surrey, British Columbia, Canada V3W 8J9;
ABC Online Pharmacy, d/b/a, https://www.abconlinepharmacy.com, 200-7382
Winston Street, Burnaby, British Columbia, V5A 2G9 Canada;
Canadadrugs.com LP, d/b/a, https://www.Canadadrugs.com, 24 Terracon
Place, Winnipeg, Manitoba, Canada R2J 4G7.
North Drug Store, d/b/a, https://www.northdrugstore.com, 266 Graham
Avenue, P.O. Box 1074 Station Main, Winnipeg, Manitoba, R3C 2X4 Canada;
Canada Pharmacy, d/b/a, https://www.CanadaPharmacy.com, 477 Peace Portal
Dr Suite 180, Blaine, WA 98230;
(c) The Commission investigative attorney, party to this
investigation, is the Office of Unfair Import Investigations, U.S.
International Trade Commission, 500 E Street, SW., Suite 401,
Washington, DC 20436; and
(4) For the investigation so instituted, the Honorable Paul J.
Luckern, Chief Administrative Law Judge, U.S. International Trade
Commission, shall designate the presiding Administrative Law Judge.
Responses to the complaint and the notice of investigation must be
submitted by the named respondents in accordance with section 210.13 of
the Commission's Rules of Practice and Procedure, 19 CFR 210.13.
Pursuant to 19 CFR 201.16(d)-(e) and 210.13(a), such responses will be
considered by the Commission if received not later than 20 days after
the date of service by the Commission of the complaint and the notice
of investigation. Extensions of time for submitting responses to the
complaint and the notice of investigation will not be granted unless
good cause therefor is shown.
Failure of a respondent to file a timely response to each
allegation in the
[[Page 17446]]
complaint and in this notice may be deemed to constitute a waiver of
the right to appear and contest the allegations of the complaint and
this notice, and to authorize the administrative law judge and the
Commission, without further notice to the respondent, to find the facts
to be as alleged in the complaint and this notice and to enter an
initial determination and a final determination containing such
findings, and may result in the issuance of an exclusion order or a
cease and desist order or both directed against the respondent.
By order of the Commission.
Issued: March 23, 2011.
James R. Holbein,
Acting Secretary to the Commission.
[FR Doc. 2011-7295 Filed 3-28-11; 8:45 am]
BILLING CODE P
